Campath Maintenance in Chronic Lymphocytic Leukemia
Status:
Terminated
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
This is a study designed to test whether giving campath (also known as alemtuzumab) on a
maintenance schedule will prolong the time until the patient requires chemotherapy.